Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897058279> ?p ?o ?g. }
- W2897058279 endingPage "304" @default.
- W2897058279 startingPage "292" @default.
- W2897058279 abstract "Previously, we demonstrated that Prx II is important for survival of the gefitinib-resistant A549 (A549/GR) cell line, an NSCLC cell line derived by repeated exposure to gefitinib. Therefore, in this study, we used A549/GR cells to investigate the role of Prx II in GR NSCLC stemness. Initially, to explore the stemness characteristics and investigate the association of Prx II with those stemness characteristics, we successfully isolated a stem cell-like population from A549/GR cells. A549/GR CD133+ cells possessed important cancer stemness characteristics, including the abilities to undergo metastasis, angiogenesis, self-renewal, and to express stemness genes and epithelial-mesenchymal transition (EMT) markers. However, those characteristics were abolished by knocking down Prx II expression. MicroRNA 122 (miR-122) targets Prx II in A549/GR cancer stem cells (CSCs), thereby inhibiting the stemness characteristics in vitro and in vivo. Next, we investigate whether miR-122 overexpression was associated with Prx II expression and Prx-II-induced stemness characteristics, we transfected miR-122 into A549/GR CSCs. MiR-122 inhibited A549/GR stemness by downregulating the Hedgehog, Notch, and Wnt/β-catenin pathways. Taken together, our data suggest that Prx II promotes A549/GR stemness, and that targeting Prx II and miR-122 is a potentially viable strategy for anti-cancer-stem cell therapy in GR NSCLCs." @default.
- W2897058279 created "2018-10-26" @default.
- W2897058279 creator A5000014076 @default.
- W2897058279 creator A5008988412 @default.
- W2897058279 creator A5036832276 @default.
- W2897058279 creator A5050935955 @default.
- W2897058279 creator A5056961218 @default.
- W2897058279 creator A5069910448 @default.
- W2897058279 creator A5078295866 @default.
- W2897058279 date "2018-10-19" @default.
- W2897058279 modified "2023-10-18" @default.
- W2897058279 title "MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells" @default.
- W2897058279 cites W1578276954 @default.
- W2897058279 cites W1974997620 @default.
- W2897058279 cites W1982217935 @default.
- W2897058279 cites W1988188873 @default.
- W2897058279 cites W2009169336 @default.
- W2897058279 cites W2015244252 @default.
- W2897058279 cites W2016331164 @default.
- W2897058279 cites W2023262010 @default.
- W2897058279 cites W2033100621 @default.
- W2897058279 cites W2036765113 @default.
- W2897058279 cites W2065277366 @default.
- W2897058279 cites W2066657193 @default.
- W2897058279 cites W2072693879 @default.
- W2897058279 cites W2075584603 @default.
- W2897058279 cites W2080645878 @default.
- W2897058279 cites W2105797313 @default.
- W2897058279 cites W2117692326 @default.
- W2897058279 cites W2124982450 @default.
- W2897058279 cites W2138064097 @default.
- W2897058279 cites W2139236349 @default.
- W2897058279 cites W2232349478 @default.
- W2897058279 cites W2260605223 @default.
- W2897058279 cites W2262045065 @default.
- W2897058279 cites W2284639409 @default.
- W2897058279 cites W2297970061 @default.
- W2897058279 cites W2344706803 @default.
- W2897058279 cites W2531260467 @default.
- W2897058279 cites W2549572275 @default.
- W2897058279 cites W2551341750 @default.
- W2897058279 cites W2566129764 @default.
- W2897058279 cites W2766584775 @default.
- W2897058279 cites W2772128545 @default.
- W2897058279 cites W2791876327 @default.
- W2897058279 cites W2806150206 @default.
- W2897058279 cites W2892260781 @default.
- W2897058279 cites W3016157719 @default.
- W2897058279 doi "https://doi.org/10.1038/s41417-018-0050-1" @default.
- W2897058279 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6760639" @default.
- W2897058279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30341415" @default.
- W2897058279 hasPublicationYear "2018" @default.
- W2897058279 type Work @default.
- W2897058279 sameAs 2897058279 @default.
- W2897058279 citedByCount "22" @default.
- W2897058279 countsByYear W28970582792019 @default.
- W2897058279 countsByYear W28970582792020 @default.
- W2897058279 countsByYear W28970582792021 @default.
- W2897058279 countsByYear W28970582792022 @default.
- W2897058279 countsByYear W28970582792023 @default.
- W2897058279 crossrefType "journal-article" @default.
- W2897058279 hasAuthorship W2897058279A5000014076 @default.
- W2897058279 hasAuthorship W2897058279A5008988412 @default.
- W2897058279 hasAuthorship W2897058279A5036832276 @default.
- W2897058279 hasAuthorship W2897058279A5050935955 @default.
- W2897058279 hasAuthorship W2897058279A5056961218 @default.
- W2897058279 hasAuthorship W2897058279A5069910448 @default.
- W2897058279 hasAuthorship W2897058279A5078295866 @default.
- W2897058279 hasBestOaLocation W28970582791 @default.
- W2897058279 hasConcept C104317684 @default.
- W2897058279 hasConcept C121608353 @default.
- W2897058279 hasConcept C137620995 @default.
- W2897058279 hasConcept C145059251 @default.
- W2897058279 hasConcept C185592680 @default.
- W2897058279 hasConcept C2779013556 @default.
- W2897058279 hasConcept C2779438470 @default.
- W2897058279 hasConcept C2780580887 @default.
- W2897058279 hasConcept C28328180 @default.
- W2897058279 hasConcept C502942594 @default.
- W2897058279 hasConcept C54355233 @default.
- W2897058279 hasConcept C55427017 @default.
- W2897058279 hasConcept C62478195 @default.
- W2897058279 hasConcept C76419328 @default.
- W2897058279 hasConcept C81729549 @default.
- W2897058279 hasConcept C81885089 @default.
- W2897058279 hasConcept C86803240 @default.
- W2897058279 hasConcept C95444343 @default.
- W2897058279 hasConceptScore W2897058279C104317684 @default.
- W2897058279 hasConceptScore W2897058279C121608353 @default.
- W2897058279 hasConceptScore W2897058279C137620995 @default.
- W2897058279 hasConceptScore W2897058279C145059251 @default.
- W2897058279 hasConceptScore W2897058279C185592680 @default.
- W2897058279 hasConceptScore W2897058279C2779013556 @default.
- W2897058279 hasConceptScore W2897058279C2779438470 @default.
- W2897058279 hasConceptScore W2897058279C2780580887 @default.
- W2897058279 hasConceptScore W2897058279C28328180 @default.
- W2897058279 hasConceptScore W2897058279C502942594 @default.
- W2897058279 hasConceptScore W2897058279C54355233 @default.